Millicent A Omondi
4PUBLICATIONS
49CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 05, 2024
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma
|Apr 11, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.Catherine Riou, Jinal N Bhiman, Yashica Ganga
|Dec 04, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.Catherine Riou, Jinal N Bhiman, Yashica Ganga
|Jul 01, 2022
Characterization of Mycobacterium tuberculosis-Specific Th22 Cells and the Effect of Tuberculosis Disease and HIV Coinfection.Mohau S Makatsa, F Millicent A Omondi, Rubina Bunjun
Pageof 1
Frequent Collaborators
4 joint publications
Wendy A Burgers
3 joint publications
Faeezah Patel
3 joint publications
Catherine Riou
3 joint publications
Penny L Moore
3 joint publications
Nigel Garrett
2 joint publications
Shobna Sawry
2 joint publications
Sashkia R Balla
2 joint publications
Ntombi Benede
2 joint publications
Carol Crowther
2 joint publications
Mrinmayee Dhar
